Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Hematologic Malignancies
Hematologic Malignancies is not currently indexed in Scopus. Published by Springer Science and Business Media Deutschland GmbH.
Checked against the index lists dated .
ISSN 2197-9766Verify ISSN ↗2197-9774Verify ISSN ↗
Publisher: Springer Science and Business Media Deutschland GmbH
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Hematologic Malignancies indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2018–2021 (also 2015–2016)).
What is the impact factor of Hematologic Malignancies?
Hematologic Malignancies has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Who publishes Hematologic Malignancies and what is its ISSN?
Hematologic Malignancies is published by Springer Science and Business Media Deutschland GmbH. Its print ISSN is 2197-9766 and its online ISSN is 2197-9774.
Is Hematologic Malignancies in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Hematologic Malignancies open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Hematologic Malignancies for 6 years, between 2015 and 2021, with 1 year in that span missing. Coverage ended in 2021, 5 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 256 works and 862 citations for the title. Its most recent paper is from 2021, in line with the end of Scopus coverage in 2021, which suggests the journal stopped publishing around then.
How well cited is Hematologic Malignancies? — open metrics via OpenAlex
Hematologic Malignancies has an h-index of 12 and a 2-year mean of 0 citations per paper (OpenAlex).
Hematologic Malignancies published 65 papers in 2021; its busiest recent year was 2020 with 66. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Are there integrity warnings for Hematologic Malignancies? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2021. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2021
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Springer Science and Business Media Deutschland GmbH
Springer Science and Business Media Deutschland GmbH has 429 other titles in our data; 393 are currently indexed in Scopus.
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.